Charmaine Lok is a Professor of Medicine at the Faculty of Medicine, University of Toronto and Senior Scientist at the Toronto General Hospital Research Institute. She is also associated with the Department of Clinical Epidemiology and Biostatistics, Faculty of Health Sciences, McMaster University. Dr. Lok is the Medical Director of both the Chronic Kidney Diseases and Hemodialysis Vascular Access Programs at the Toronto General Hospital.
Charmaine E Lok
Dr. Lok is a clinical trialist with a research focus on chronic kidney disease (CKD) and endstage kidney disease (ESKD) outcomes. She has a special interest in improving hemodialysis vascular access outcomes, improving neuromuscular function and mobility in CKD and reducing cardiovascular events and mortality in CKD/ESRD. She is also active in raising awareness of CKD and ESRD and its importance in population health.
Clin J Am Soc Nephrol. 2017 Jul 20;:
Clin J Am Soc Nephrol. 2017 Jul 05;:
Endovascular Proximal Forearm Arteriovenous Fistula for Hemodialysis Access: Results of the Prospective, Multicenter Novel Endovascular Access Trial (NEAT).
Am J Kidney Dis. 2017 Jun 09;:
Clin J Am Soc Nephrol. 2017 Jun 09;:
Semin Nephrol. 2017 Mar;37(2):151-158
BMJ Open. 2017 Mar 24;7(3):e011720
Establishing patient-specific criteria for selecting the optimal upper extremity vascular access procedure.
J Vasc Surg. 2017 Feb 17;:
J Am Soc Nephrol. 2016 Dec 28;:
Clin J Am Soc Nephrol. 2016 Sep 14;
Hospitalization Rates for Patients on Assisted Peritoneal Dialysis Compared with In-Center Hemodialysis.
Clin J Am Soc Nephrol. 2016 Jul 27;
Senior Scientist, Toronto General Hospital Research Institute (TGHRI)
Associate Professor, Department of Medicine, University of Toronto
Faculty, Institute of Health Policy, Management & Evaluation, University of Toronto
Department of Clinical Epidemiology and Biostatistics, Faculty of Health Sciences, McMaster University